Ambu drops 10% to bottom of STOXX after Q2 miss

Ambu A/S

07/05/2025 08:15

** Shares in Ambu AMBUb.CO fall around 10% after the Danish medical equipment maker reported Q2 sales and earnings below expectations

** Q2 sales came in at DKK 1.55 billion ($236.21 million) and adjusted EBIT at DKK 224 million, which J.P.Morgan says missed consensus by 1% and 11% respectively

** The broker also notes that the Endoscopy division missed sales expectations by 2.7%

** "Whilst some investors will find relief in a guidance reiteration (amidst concerns around tariff headwinds), we think the focus will be on the endoscopy growth miss ... and EBIT margin miss for Q2," adds JPM

** Ambu reiterated its outlook for the financial year 2024/25, saying that "with today's status on tariffs" it was confident to deliver on the guidance

** Shares trade at their lowest in one month and hit bottom of STOXX 600 .STOXX index; up to Tuesday's close they were up 16% YTD

($1 = 6.5620 Danish crowns)

 (Reporting by Greta Rosen Fondahn)

 ((Greta.RosenFondahn@thomsonreuters.com))